Suo‐Bao Rong
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Protein Kinase Regulation and GTPase Signaling, Computational Drug Discovery Methods, Stress Responses and Cortisol, Chemical Synthesis and Analysis
Most-Cited Works
- → 3-(Hydroxymethyl)-Bearing Phosphatidylinositol Ether Lipid Analogues and Carbonate Surrogates Block PI3-K, Akt, and Cancer Cell Growth(2000)194 cited
- → Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia(2012)89 cited
- → Molecular Modeling Studies of the Akt PH Domain and Its Interaction with Phosphoinositides(2001)51 cited
- → Structural Basis of Bloom Syndrome (BS) Causing Mutations in the BLM Helicase Domain(2000)37 cited
- → Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain(2000)33 cited
- → PF-04859989 as a template for structure-based drug design: Identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency(2013)31 cited
- → Discovery of a novel Kv7 channel opener as a treatment for epilepsy(2015)22 cited
- → Discovery of hydroxamate bioisosteres as KAT II inhibitors with improved oral bioavailability and pharmacokinetics(2012)20 cited
- → The synthesis of substituted (4S)-4-(hydroxymethyl)imidazolidin-2-ones as novel protein kinase C modulators(2000)9 cited
- Interaction models of 3-methylfentanyl derivatives with mu opioid receptors.(1997)